Chapter Summary
In this chapter, Inmaculada de Melo-Martin and Marin Gillis begin by presenting some background on embryonic stem cells, including on why their distinctive feature — the capacity to differentiate into any type of cell in the body — is thought to hold so much biomedical research and therapeutic potential. They then explore the ethical issues raised by the use of stem cells in research and treatment. Among the issues they discuss are: the moral status of the embryos that are destroyed in the derivation of stem cells; safety and informed consent by patients who undergo stem cell based therapies; obtaining ova from women to create embryos for research; and justice concerns related to the inequality in access to novel medical technologies.
This chapter is excerpted from Inmaculada de Melo-Martin and Marin Gillis (2010) ‘Ethical Issues in Human Stem Cell Research: Embryos and Beyond,’ in Technology and Human Values: Essential Readings, ed. C. Hanks (Wiley-Blackwell). It appears here by permission of the authors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Works Cited
M. R. Alison, et al. (2000) ‘Hepatocytes from non-hepatic adult stem cells,’ Nature, 406: 257.
S. Altman (1991) ‘Commodifying Experience,’ Southern California Law Review, 65: 293–340, 293.
M. Amit, et al. (2003) ‘Human Feeder Layers for Human Embryonic Stem Cells,’ Biological Reproduction, 68(6): 2150–6.
The Bellagio Task Force Report on Transplantation, Bodily Integrity, and the International Traffic in Organs Available at www.icrc.org/Web/eng/siteeng0.nsf/iwpList302/87DC95FCA3C3D63EC1256B66005B3F6C (accessed April 2006).
F. Baylis (2000) ‘Our Cells/Ourselves: Creating Human Embryos for Stem Cell Research,’ Women’s Health Issues, 10(3): 140–5.
M. Brehm, T. Zeus, and B. E. Strauer (2002) ‘Stem cells — clinical application and perspectives, Herz, 27(7): 611–20.
L. S. Cahill (2000) ‘Social ethics of embryo and stem cell research,’ Women’s Health Issues, 10: 131–5.
Y. Chung, I. Klimanskaya, S. Becker, et al. (2005) ‘Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres,’ Nature (Oct 16).
I. de Melo-Martin (1997) Making Babies. Biomedical Technologies, Reproductive Ethics, and Public Policy (Dordrecht: Kluwer University Press).
I. de Melo-Martin, and C. Hanks (2001) ‘Genetic technologies and women: the importance of context,’ Bulletin of Science, Technology & Society, 21(5): 354–60.
D. Dickenson (2001) ‘Property and women’s alienation from their own labour,’ Bioethics 15: 204–17.
S. Dodds (2004) ‘Women, commodification, and embryonic stem cell research’ in Stem Cell Research: Biomedical Ethics Reviews, J. Humber and R. Almeder, (eds) (Towota, New Jersey: Humana Press).
R. M. Doerflinger (1999) ‘The ethics of funding embryonic stem cell research: a Catholic viewpoint,’ Kennedy Institute of Ethics Journal, 9: 137–50.
M. A. Eglitis, and E. Mezey (1997) ‘Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice,’ Proceedings of the National Academy of Sciences USA 94: 4080–5.
R. Faden, and T. Beauchamp (1986) A History and Theory of Informed Consent (New York: Oxford University Press).
G. Ferrari, et al. (1998) ‘Muscle regeneration by bone marrow-derived myogenic progenitors,’ Science, 279: 1528–30.
S. Filip, J. Mokry, and I. Hruska (2003) ‘Adult stem cells and their importance in cell therapy,’ Folia Biologica, 49(1): 9–14.
R. Green (2001) The Human Embryo Research Debates: Bioethics in the Vortex of Controversy (New York: Oxford University Press).
A-K. Hadjantonakis, V. E. Papaioannou (2001) ‘The stem cells of early embryos,’ Differentiation, 68: 159–166.
S. Hall (2003) ‘The Recycled Generation,’ New York Times Magazine (January): 30.
T. Hamasaki et al. (2003) ‘Neuronal cell migration for the developmental formation of the mammalian striatum,’ Brain Research. Brain Research Reviews, 41(1): 1–12.
Q. He et al. (2003) ‘Embryonic stem cells: new possible therapy for degenerative diseases that affect elderly people,’ Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 58(3): 279–87.
R. Hoedemaekers, H. ten Have, R. Chadwick (1997) ’Genetic screening: a comparative analysis of three recent reports,’ Journal of Medical Ethics 23(3): 135–41.
S. Holland (2001) ‘Contested commodities at both ends of life: buying and selling gametes, embryos, and body tissues,’ Kennedy Institute of Ethics Journal, 11(3): 263–84.
S. Holland, and D. Davis (eds) (2001) ‘Special Issue: Who’s afraid of commodification,’ Kennedy Institute of Ethics Journal, 11.
J. Katz (1972) Experimenting with Human Beings (New York: Russell Sage Foundation).
L. Knowles (1999) ‘Property, patents, progeny,’ Hastings Center Report, 2: 38–40.
A. Lakatos, and R. J. Franklin (2002) ‘Transplant mediated repair of the central nervous system: an imminent solution?’ Current Opinion Neurology, 15(6): 701–5.
P. Lauritzen (2001) ‘Neither person nor property: embryo research and the status of the early embryo,’ America, (March 26).
J. W. Lim, and A. Bodnar (2002) ‘Proteome analysis of conditioned medium from mouse embryonic fibroblast feeder layers which support the growth of human embryonic stem cells,’ Proteomics, 2(9): 1187–203.
K. Margolin (2002) ‘High dose chemotherapy and stem cell support in the treatment of germ cell cancer,’ Journal of Urology, 169(4): 1229–33.
D. Marquis (1989) ‘Why Abortion Is Immoral,’ Journal of Philosophy, 86(4): 470–86.
K. A. Marr, et al. (2002) ‘Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors,’ Blood, 100(13): 4358–66.
G. McGee, and A. Caplan (1999) ‘The ethics and politics of small sacrifices in stem cell research,’ Kennedy Institute of Ethics Journal, 9(2): 151–8.
A. McLaren (2001) Ethical and social considerations of stem cell research, Nature 414: 129–31.
G. Meilaender (2001) ‘The point of a ban: or how to think about stem cell research,’ Hastings Center Report, 31(1): 9–16.
A. Meissner, and R. Jaenisch (2005) ‘Generation of nuclear transfer-derived pluripotent ES cells from cloned Cdx2-deficient blastocysts,’ Nature, (Oct 16).
J. R. Meyer (2002) ‘Human embryonic stem cells and respect for life,’ Journal of Medical Ethics, 26: 166–70.
M. J. Meyer, and L. J. Nelson (2001) ‘Respecting what we destroy: reflections on human embryo research,’ Hastings Center Report, 31: 16–23.
T. Murray (2005) ‘Will new ways of creating stem cells dodge the objections?’ Hastings Center Report 32(1): 8–9.
National Institutes of Health (2002) ‘Stem Cells: A Primer, Bethesda, Maryland: National Institutes of Health,’ available at www.nih.gov/news/stemcell/primer.htm (accessed April 6, 2003).
National Research Council and the Institute of Medicine (2002) ‘Stem Cell and the Future of Regenerative Medicine,’ (Washington, DC: National Academy Press).
J. Noonan (1970) ‘An almost absolute value in history,’ in The Morality of Abortion: Legal and Historical Perspectives, (ed.) J. Noonan (Cambridge, MA: Harvard University Press).
D. Orlic et al. (2001) ‘Bone marrow cells regenerate infarcted myocardium,’ Nature 410: 701–4.
T. Ostenfeld, and C. N. Svendsen (2003) ‘Recent advances in stem cell neurobiology,’ Advances and Technical Standards in Neurosurgery, 28: 3–89.
G. Outka (2002) ‘The ethics of human stem cell research,’ Kennedy Institute of Ethics Journal 12(2): 175–214.
B. Peault, E. Oberlin, and M. Tavian (2002) ‘Emergence of hematopoietic stem cells in the human embryo,’ Comptes Rendus Biology 325(10): 1021–6.
R. Poulsom, et al. (2001) ‘Bone marrow contributes to renal parenchymal turnover and regeneration,’ Journal of Pathology, 195: 229–35.
S. L. Preston (2003) ‘The new stem cell biology: something for everyone,’ Molecular Pathology, 56(2): 86–96.
M. J. Raddin (1991) ‘Reflections on objectification,’ Southern California Law Review, 65: 341–54.
M. Raddin (1989) ‘Justice and the market domain,’ in R. Pennock and J. Chapman (eds), Markets and Justice (New York: New York University Press).
J. Rawls (1971) A Theory of Justice (Cambridge, MA: Harvard University Press).
D. Resnik (2001) ‘Regulating the Market for Human Eggs,’ Bioethics, 15: 1–25.
I. N. Rich (2003) ‘In vitro hematotoxicity testing in drug development: a review of past, present and future applications,’ Current Opinion Drug Discovery Development, 6(1): 100–9.
M. Richards, et al. (2002) ‘Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells,’ Nature Biotechnology, 20(9): 933–6.
D. Rothman (1999) ‘The international organ traffic,’ in Moral Issues in a Global Perspective (ed.) C. Koggel (Peterborough, Ontario: Broadview Press): 611–18.
R. Sample (2003) Exploitation: What It Is and Why It’s Wrong (Lanham, MD: Rowman and Littlefield).
N. Scheper-Hughes (2000) ‘The global traffic in human organs,’ Current Anthropology, 41 (April): 2–19.
H. Semb (2005) ‘Human embryonic stem cells: origin, properties and applications,’ APMIS, 113(11–12): 743–50.
L. Shanner (2001) ‘Stem cell terminology: practical, theological and ethical implications,’ Health Law Review Papers (September 2): 62–6.
P. Smaglik (1999) ‘Promise and problems loom for stem cell gene therapy,’ Scientist, 13:14–15.
D. Solter, and J. Gearhart (1999) ‘Putting stem cells to work,’ Science, 283(5407): 1468–70.
D. Spar (2004) ‘The business of stem cells,’ New England Journal of Medicine, 351: 211–13.
B. Steinbock (2000) ‘What does ‘respect for embryos’ mean in the context of stem cell research?’ Women’s Health Issues, 10(3): 127–30.
C. Strong (1997) ‘The moral status of preembryos, embryos, fetuses, and infants,’ Journal of Medical Philosophy, 22: 457–78.
United Network of Organ Sharing, a US non-profit organization and clearing house. Available at www.unos.org (accessed April 2006).
A. Vats, et al. (2002) ‘Stem cells: sources and applications,’ Clinical Otolaryngology, 27(4): 227–32.
M. Warren (1973) ‘On the Moral and Legal Status of Abortion,’ The Monist, 57(1): 43–61.
M. Warren (1997) Moral Status: Obligations to Persons and Other Living Things (New York: Oxford University Press).
A. Werthheimer (1999) Exploitation (Princeton, NJ: Princeton University Press).
Editor information
Editors and Affiliations
Copyright information
© 2014 Inmaculada de Melo-Martin and Marin Gillis
About this chapter
Cite this chapter
de Melo-Martin, I., Gillis, M. (2014). Ethical Issues in Human Stem Cell Research: Embryos and Beyond. In: Sandler, R.L. (eds) Ethics and Emerging Technologies. Palgrave Macmillan, London. https://doi.org/10.1057/9781137349088_9
Download citation
DOI: https://doi.org/10.1057/9781137349088_9
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-0-230-36703-6
Online ISBN: 978-1-137-34908-8
eBook Packages: Palgrave Religion & Philosophy CollectionPhilosophy and Religion (R0)